Tata Elxsi has announced a major step in the healthcare technology space with the launch of the Bayer Development Centre in Radiology. The new facility, located in Pune, India, aims to develop advanced radiology devices that support early and accurate diagnosis of critical illnesses. This initiative combines the strengths of Tata Elxsi and Bayer, a leader in radiology, to bring safe and compliant medical solutions to healthcare professionals worldwide.
The centre is designed to accelerate innovation in radiology technology. By integrating design, development, and validation under one roof, it will streamline the entire process of bringing advanced medical devices to market. This approach not only reduces time-to-market but also ensures that products are delivered efficiently and meet the strictest global regulatory standards.
A key initial focus of the centre is on Molecular Imaging, a rapidly advancing field in medical diagnostics. The goal is to provide healthcare providers with tools that enable earlier detection and more accurate assessment of diseases. This can make a substantial difference in treatment outcomes for patients across the globe.
The collaboration highlights Tata Elxsi’s extensive expertise in healthcare engineering. Supported by the Tata ecosystem and India’s growing technological capabilities, the centre has access to advanced laboratories, regulatory partnerships, and specialised talent. This strong foundation ensures scalability and supports Bayer’s efforts to expand radiology solutions to markets in the United States, Europe, and beyond.
Speaking about the collaboration, Dr. Konstanze Diefenbach, Head of Research & Development, Radiology, Bayer, emphasized the importance of device innovation in diagnostic imaging. She noted that Bayer is committed to maintaining high standards of precision and safety, and that Tata Elxsi’s specialised engineering capabilities will allow Bayer to speed up its pipeline of advanced radiology devices.
From Tata Elxsi’s perspective, the new centre represents more than just an engineering hub. According to Sreevatsa Sahasranaman, Senior Vice President & Head – Healthcare & Life Sciences, the partnership brings together Bayer’s radiology vision and Tata Elxsi’s strengths in design, AI/ML, and regulatory expertise. The goal is to create devices that address real-world challenges in diagnostics while ensuring safety, compliance, and scalability.
This collaboration also reinforces Bayer’s mission of delivering innovative solutions to healthcare providers. By combining Bayer’s clinical expertise with Tata Elxsi’s technological strength, the centre can serve as a catalyst for medical device innovation. The partnership is expected to set benchmarks in how radiology devices are designed, tested, and brought into clinical use.
Tata Elxsi has already built a strong reputation as a global design and technology services company. Headquartered in Bangalore, it operates across industries such as healthcare, automotive, broadcast, and consumer electronics. With design studios and development centres worldwide, it offers end-to-end services that add value at every stage of product development.
In healthcare specifically, Tata Elxsi’s practice is ISO 13485 certified, which underlines its adherence to quality and regulatory standards. It partners with leading medical device companies, pharmaceutical firms, and technology providers to deliver solutions that meet both clinical and commercial needs. This certification ensures that all medical technology developed aligns with international standards for safety and effectiveness.
The new radiology centre also plays into Tata Elxsi’s broader strategy of leveraging AI and machine learning. These technologies are increasingly vital in healthcare, especially in diagnostics where large amounts of imaging data must be processed. Tata Elxsi’s expertise in AI/ML positions it well to support Bayer in developing next-generation radiology devices that are both intelligent and reliable.
For Bayer, the collaboration strengthens its global innovation network. Radiology remains a crucial part of its healthcare portfolio, and this centre gives the company a direct pathway to advanced engineering talent and facilities. It ensures that Bayer can continue to deliver products trusted by healthcare providers across multiple regions.
This development is also significant for India’s role in global healthcare innovation. By hosting such a major facility in Pune, India is further establishing itself as a hub for advanced medical technology. The collaboration highlights the country’s growing importance in global healthcare engineering and regulatory compliance.
As the centre begins its operations, both companies expect to deliver tangible results that impact patients worldwide. The combination of clinical expertise, design innovation, and advanced engineering will help create devices that truly improve patient care. By focusing on critical illnesses and ensuring the highest levels of safety, the centre is set to make a meaningful contribution to healthcare.
With this new initiative, Tata Elxsi and Bayer are not just addressing current needs in radiology but also preparing for the future. The partnership reflects a shared vision of improving healthcare outcomes through technology and innovation. As work at the centre progresses, it is expected to pave the way for breakthroughs that redefine diagnostic imaging for years to come.
Tata Elxsi’s long-standing reputation in technology consulting and product development ensures that the collaboration has a strong backbone. Combined with Bayer’s clinical expertise and commitment to quality, the radiology technology centre in Pune marks a new era of medical device innovation that could reshape diagnostics on a global scale.